RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 6.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $20,520 | -16.3% | 19,000 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $24,510 | -2.3% | 19,000 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $25,080 | -12.0% | 19,000 | 0.0% | 0.00% | -50.0% |
Q4 2022 | $28,500 | +29.5% | 19,000 | 0.0% | 0.00% | +100.0% |
Q3 2022 | $22,000 | +4.8% | 19,000 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $21,000 | -63.8% | 19,000 | -2.6% | 0.00% | -66.7% |
Q1 2022 | $58,000 | +13.7% | 19,504 | +0.5% | 0.00% | +50.0% |
Q4 2021 | $51,000 | -27.1% | 19,398 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $70,000 | -16.7% | 19,398 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $84,000 | +27.3% | 19,398 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $66,000 | -2.9% | 19,398 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $68,000 | +47.8% | 19,398 | +2.1% | 0.00% | +33.3% |
Q3 2020 | $46,000 | +31.4% | 19,000 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $35,000 | +16.7% | 19,000 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $30,000 | -23.1% | 19,000 | +5.6% | 0.00% | -25.0% |
Q4 2019 | $39,000 | +14.7% | 18,000 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $34,000 | – | 18,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |